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INTRODUCTION
Fetal programming associated with intrauterine
growth restriction (IUGR) leads to lifelong deficits in growth and metabolic function (Hales and
Barker, 2013). IUGR arises when fetuses respond
to poor in utero conditions by developing adaptations that repartition nutrients to critical tissues
and away from skeletal muscle (Yates et al., 2012,
2018). This fetal programming is beneficial in utero
but leads to persistent reductions in muscle mass
and glucose homeostasis in offspring (DeFronzo
et al., 1981). Recent studies by our laboratory in
sheep and rats demonstrate that maternal inflammation during gestation induces fetal inflammatory adaptations that impair growth and disrupt
muscle glucose metabolism (Cadaret et al., 2017,
2018). IUGR fetal skeletal muscle exhibits indicators of enhanced inflammatory sensitivity, which
could disrupt glucose uptake and oxidation (Yates
et al., 2016; Cadaret et al., 2018). Enhanced inflammatory responsiveness would help explain growth
and metabolic deficits observed in IUGR offspring.
We hypothesize that fetal programming induced by
maternal inflammation persists in offspring and
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contributes to impaired growth and glucose metabolism at 30 d. Therefore, the objective of this study
was to determine whether sustained maternal inflammation induced by bacterial endotoxin at 0.7
gestation leads to fetal programming that contributes to deficits in growth and glucose metabolism
in offspring.
MATERIALS AND METHODS
Animals and Experimental Design
All procedures were approved by the
Institutional Animal Care and Use Committee
at the University of Nebraska–Lincoln, which
is an AAALAC International accredited institution. Timed-mated Polypay ewes were treated
(iv) with saline (control, n = 8) or 0.1 µg/kg bodyweight (BW) of bacterial lipopolysaccharide
(n = 6; Escherichia coli O55:B5; MilliporeSigma)
every third day from d 100 to 115 of gestation to
produce maternal inflammation-induced IUGR
(MI-IUGR) lambs. Lambs were weaned at birth,
fed colostrum, and transitioned to a commercial
milk replacer (ad libitum). BW and growth metrics were measured at birth and 30 d. At 25 ± 2,
indwelling catheters and a perivascular flow probe
were surgically placed in hindlimb femoral arteries
and veins as previously described (Limesand et al.,
2007; Camacho et al., 2017). Glucose-stimulated
insulin secretion (GSIS) and hyperinsulinemic-euglycemic clamp (HEC) studies were performed
at 28 ± 2 and 29 ± 2 d, respectively. Lambs were
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killed at 30 ± 2 d. Brains were weighed, and primary hindlimb skeletal muscle was isolated for ex
vivo metabolic studies.

was calculated in nanomol using the specific activity
of the infused radiolabeled glucose.
Ex Vivo Skeletal Muscle Glucose Metabolism

Glucose-Stimulated Insulin Secretion
A square-wave hyperglycemic clamp was performed as previously described (Yates et al., 2012;
Camacho et al., 2017). Three baseline samples were
collected at 5-min intervals prior to an intravenous
glucose bolus (150 mg/kg BW) and continuous
variable-rate glucose infusion to produce steadystate hyperglycemia ~2-fold greater than baseline.
Thirty minutes after clamping hyperglycemia, three
additional blood samples were collected at 5-min
intervals. Blood was centrifuged (14,000 × g, 2 min,
4 ºC) and plasma insulin concentrations were determined via ELISA (Ovine Insulin; Alpco). Intra- and
inter-assay coefficient of variation were less than
10%. Whole blood was analyzed for glucose concentration using an ABL90 FLEX (Radiometer).
Hindlimb Glucose Metabolism
Hindlimb glucose utilization and oxidation
rates at baseline and during HEC were quantified as
previously described (Cadaret et al., 2018). Lambs
were infused with U-[14C]-glucose tracer (18.75 µCi/
ml; PerkinElmer) at 1 ml/h for 40 min. Then, arterial
and venous blood samples were collected simultaneously at 5-min intervals (four total). Lambs were
then infused with 33% dextrose at a variable rate
and insulin (Humulin-R; Eli Lilly) at 4 mU/kg/min
to produce steady-state hyperinsulinemia and euglycemia. After HEC was achieved for 2 h, simultaneous venous and arterial samples were again taken
at 5-min intervals as described earlier. To measure
glucose oxidation, blood was added to microcentrifuge tubes containing 2 M HCl to release CO2. These
were suspended inside sealed 20-ml scintillation vials
containing 1 M NaOH to capture CO2. After 24 h
at 32 ºC, the microcentrifuge tube was removed and
Ultima Gold scintillation fluid (PerkinElmer) was
added to each vial. Concentrations of 14CO2 from
each blood sample were quantified via liquid scintillation using a Beckman Coulter 1900. Hindlimb
glucose utilization was calculated as the difference
between arterial and venous glucose concentrations
normalized to femoral blood flow rate and hindlimb
weight at necropsy. Hindlimb glucose oxidation
rates were quantified in triplicate from the difference
between venous and arterial 14C-specific activities
normalized to femoral blood flow rate and hindlimb
weight at necropsy. The amount of glucose oxidized

Primary skeletal muscle glucose uptake and
oxidation rates were quantified as previously described (Cadaret et al., 2017). The flexor digitorum
superficialis muscle of each lamb was dissected longitudinally into ~800 mg strips before incubation
in Krebs–Henseleit bicarbonate buffer (KHB) containing (basal), or 5 mU/ml insulin. Glucose uptake
was measured in triplicate by incubating muscle in
KHB containing 1 mM [3H]2-deoxyglucose and
1 mM [14C]-mannitol for 20 min. Glucose oxidation
was measured in triplicate by incubating muscle in
KHB containing [14C-U]D-glucose for 2 h, before
capturing 14CO2 in NaOH for 2 h as previously described (Cadaret et al., 2017).
Statistical Analysis
All data were analyzed using the MIXED
procedure in SAS (SAS Institute, Cary, NC) with
lamb as the experimental unit. In vivo and ex vivo
metabolic data were analyzed for effects due to
experimental group, period (or incubation condition), and the interaction. Period or condition was
treated as a repeated variable. For in vivo metabolic studies, samples within each period were
averaged for each lamb. Similarly, technical replications were averaged for each lamb in ex vivo
studies. Morphometric data were analyzed for effects due to treatment. All data are presented as
means ± SEM.
RESULTS
Lamb Growth Metrics
At birth, BW tended to be less (P < 0.1) and average
daily gain (ADG) from birth to d 30 was less (P < 0.05)
in MI-IUGR lambs than controls (Table 1). At 30 d,
BW was ~20% less (P < 0.05) in MI-IUGR lambs
than controls. Brain weight or BW was ~19% greater
(P < 0.05) in MI-IUGR lambs compared to controls.
In Vivo Metabolic Studies
Basal and GSIS did not differ between groups
(Figure 1). Insulin-stimulated hindlimb glucose
rates did not differ between groups (data not
shown). However, hindlimb insulin-stimulated
glucose oxidation was ~70% less (P < 0.05) in
MI-IUGR lambs compared to controls (Figure 2).
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DISCUSSION
The results of this study demonstrate that sustained maternal inflammation at 0.7 gestation yields
IUGR and growth deficits that persist after birth.
Furthermore, fetal programming responses to maternal inflammation impaired skeletal muscle glucose metabolism, which also persist after birth. In
addition to exhibiting asymmetrical growth restriction at birth, MI-IUGR lambs grew ~22% slower,
making them ~20% smaller at 30 d. Greater brain
or BW in MI-IUGR lambs was consistent with
asymmetrical growth and brain-sparing, which
is a hallmark characteristic of IUGR (Limesand
et al., 2007). Maternal inflammation yielded less severe IUGR with a less pronounced effect on BW at
birth than the maternal hyperthermic model (Yates
et al., 2018). However, our findings indicate that
MI-IUGR growth deficits persist in offspring. It is
worth noting that MI-IUGR lambs did not exhibit
postnatal catch up growth over the first 30 d after
birth in this study. Nevertheless, our MI-IUGR
lambs exhibited substantially less glucose oxidation within hindlimb tissues and in isolated hindlimb skeletal muscle. Although hindlimb tissues in
MI-IUGR lambs used normal amounts of glucose,
ex vivo studies indicated that skeletal muscle-specific glucose uptake was impaired. We did not observe evidence of β-cell dysfunction in this study,
which contrasted with the results of our fetal studies
in this model of IUGR (Cadaret et al., 2018). These
findings indicate that sustained maternal inflammation at 0.7 gestation has a substantial negative
Table 1. Growth measurements for MI-IUGR lambs
Variable
Birthweight, kg
30 d BW, kg
ADG, kg/day
30 d Brain/BW

Control
4.42 ± 0.16
13.88 ± 0.37
0.32 ± 0.01
5.91 ± 0.15

MI-IUGR
3.61 ± 0.43
11.06 ± 0.92
0.25 ± 0.02
7.23 ± 0.34

P value
0.09
0.03
0.03
0.02

Values are expressed as means ± SE. ADG = average daily gain.

25
Control
Plasma Insulin, ng/ml

Basal and insulin-stimulated glucose uptake
rates in primary skeletal muscle from MI-IUGR
lambs was less (P < 0.05) than skeletal muscle from
controls (Figure 3A). Incubation with insulin increased (P < 0.05) glucose uptake in skeletal muscle
from all lambs. Glucose oxidation rates were less
(P < 0.05) in MI-IUGR muscle than controls under
basal and insulin-stimulated conditions (Figure
3B). Insulin increased (P < 0.05) glucose oxidation
in skeletal muscle from all lambs.

effect on fetal programming of glucose metabolism
that mirrored other IUGR models (Limesand et al.,
2007; Brown et al., 2015). They further show that
adaptive fetal programming responses to maternal
inflammation persist in offspring at 30 d and affect
muscle tissue responsiveness to insulin. Reductions
in muscle glucose oxidation could be due to the
developmental shift toward anaerobic glycolysis
(Brown et al., 2015; Yates et al., 2018), which produces lactate for nutrient repartitioning via the
Cori cycle. We hypothesized in previous studies
that this shift results from programming of skeletal muscle inflammatory signaling that occurs as
a result of maternal inflammation (Cadaret et al.,
2018; Posont et al., 2018). Such alterations appear
to enhance skeletal muscle sensitivity to inflammatory cytokines, which would help to explain in part
the growth and metabolic pathologies we observed
in this study (Posont et al., 2018; Yates et al., 2018).

MI-IUGR
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Figure 1. Plasma insulin concentrations in MI-IUGR lambs at 30
d of age under basal and steady-state hyperglycemic conditions as well
as the difference between periods. Square-wave hyperglycemic clamps
were performed in controls (n = 8) and MI-IUGR (n = 6) lambs.
*Means differ (P < 0.05) from controls within the period.
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Figure 2. Hindlimb-specific insulin-stimulated glucose oxidation rates in MI-IUGR lambs at 30 d of age. Square-wave hyperinsulinemic-euglycemic clamps were performed in controls (n = 8) and
MI-IUGR (n = 6) lambs. *Means differ (P < 0.05) from controls.
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and asymmetrical growth restriction are common
characteristics of IUGR offspring in humans and
livestock. The results of this study indicated that
fetal programming responses to maternal inflammation persist after birth and contribute to deficits
in growth and glucose metabolism via unknown
mechanisms. These programmed responses may be
due to previously observed alterations in inflammatory signaling pathways of skeletal muscle, which
could represent intervention targets to improve
outcomes in IUGR offspring.
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